Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
amgen
archive
artificial intelligence
biotech
boston blog main
boston top stories
cholesterol
clinical trials
coronavirus
data
healthcare
inclisiran
ldl
mark timney
mt sinai hospital
national
national top stories
new york
new york blog main
new york top stories
pcsk9
peter wijngaard
pfizer
praluent
prashant vaishnava
regeneron pharmaceuticals
repatha
san francisco blog main
san francisco top stories
sanofi
the medicines co.
What
ceo
3
×
drug
3
×
medicine
3
×
announced
big
aces
addressed
alex
answers
cholesterol
collaboration
cost
covid
discovery
early
entered
flexible
gilead
hasten
inclisiran
indicated
insilico
key
lowering
meant
medco
medicines
nasdaq
open
passed
pfizer
positive
pricing
question
recove
remdesivir
research
sciences
surrounding
taken
Language
unset
Current search:
drug
×
ceo
×
medicine
×
@slashgear.com
3 years ago
Gilead CEO answers big COVID-19 question: How much will remdesivir cost
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
